Search - tctmd.com

Displaying 61 - 80 of 319

Sort: Relevancy | Date

News Daily News

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Michael O'Riordan

May 03, 2023

News Conference News ACC 2023

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Caitlin E. Cox

March 14, 2023

News Conference News ACC 2023

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Michael O'Riordan

March 13, 2023

News Conference News ACC 2023

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

Michael O'Riordan

March 04, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2023

Shelley Wood

March 01, 2023

News Daily News

In COVID-19 Patients, Vaccination Linked to Lower MACE Risk

Michael O'Riordan

February 22, 2023

News Daily News

Nuisance Bleeds on DAPT Not Just an Annoyance: TALOS-AMI Analysis

Caitlin E. Cox

November 30, 2022

News Daily News

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Michael O'Riordan

August 16, 2022

News Daily News

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

Yael L. Maxwell

June 03, 2022

News Conference News EAS 2022

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Michael O'Riordan

May 24, 2022

News Conference News EuroPCR 2022

Registry Data Hint at MACE Benefit With Renal Denervation

Michael O'Riordan

May 17, 2022

News Opinion CV Team Dispatch

April 2022 News Roundup

L.A. McKeown

April 01, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

News Daily News

DISCHARGE Hailed as a Big Step Forward for CTA in Stable Chest Pain

Michael O'Riordan

March 04, 2022

News Opinion CV Team Dispatch

March 2022 News Roundup

L.A. McKeown

March 01, 2022

News Daily News

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Michael O'Riordan

February 10, 2022

News Daily News

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Yael L. Maxwell

December 24, 2021

News Daily News

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

Michael O'Riordan

December 23, 2021

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Daily News

Discharge Safe as Early as a Day After Primary PCI for STEMI

L.A. McKeown

December 15, 2021

Advertisement

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Clear CVD Benefit With Bempedoic Acid: CLEAR Outcomes

TCTMD’s Top 10 Most Popular Stories for February 2023

In COVID-19 Patients, Vaccination Linked to Lower MACE Risk

Nuisance Bleeds on DAPT Not Just an Annoyance: TALOS-AMI Analysis

After COVID-19, Unvaccinated at Risk for Long-term CVD Complications

Following Takotsubo, Men Have Worse Outcomes, Are More Likely to Die Than Women

ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering

Registry Data Hint at MACE Benefit With Renal Denervation

April 2022 News Roundup

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

DISCHARGE Hailed as a Big Step Forward for CTA in Stable Chest Pain

March 2022 News Roundup

Homozygous FH Diagnosis Often Comes Late, With Lackluster Care

Another Win for Guided P2Y12 Therapy in ACS: Meta-analysis

Black Patients With Chest Pain Differ From Whites, but Risks Are Similar

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Discharge Safe as Early as a Day After Primary PCI for STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content